(a)[3]
Which type of market structure is Unilever most likely to operate in? Explain your answer.
(b)[5]
Why might it be believed that there could be a conflict between Unilever’s stated objective and its policy on suppliers?
(c)[4]
GSK’s new drug was expensive to research and develop. Why would a company still carry out research and development (R&D) when it is so costly?
(d)[8]
Discuss whether the information provides enough evidence to conclude that the objective of Unilever and GSK is not that of profit maximisation.